Fundraising FoxSparingVision’s website
3 known investors
Find your way into SparingVision’s website
SparingVision develops neuroprotective gene therapies for rare genetic diseases affecting the eye and nervous system. The company's lead candidate, SPVN06, is being evaluated in the PRODYGY clinical trial.
Investors · 3
AdBio partnerslisted by AdBio partnersParis
How we know: AdBio partners's portfolio page · Not right? Tell us
Jeito Capitallisted by Jeito CapitalParis
How we know: Jeito Capital's portfolio page · Not right? Tell us
Ysios Capitallisted by Ysios CapitalBarcelona · $5.4M – $21.6M
How we know: Ysios Capital's portfolio page · the VCSheet dataset · Not right? Tell us
Frequently asked questions
- What does SparingVision’s website do?
- SparingVision develops neuroprotective gene therapies for rare genetic diseases affecting the eye and nervous system. The company's lead candidate, SPVN06, is being evaluated in the PRODYGY clinical trial.
- Who are SparingVision’s website's investors?
- SparingVision’s website's investors include AdBio partners, Jeito Capital, Ysios Capital.